L. Levels

Preclinical safety and immunogenicity evaluation of a nonavalent PorA native outer membrane vesicle vaccine against serogroup B meningococcal disease.

H. V. van Dijken, P. Kaaijk, G. P. van den Dobbelsteen, 2013, Vaccine.

Evaluation of two serological methods for potency testing of whole cell pertussis vaccines.

C. von Hunolstein, M. Halder, S. Hoffmann, 2008, Pharmeuropa bio.

Characterization and standardization of Sabin based inactivated polio vaccine: proposal for a new antigen unit for inactivated polio vaccines.

W. Bakker, Javier Martin, G. Kersten, 2011, Vaccine.

Quality-control issues and approaches in vaccine development

L. A. van der Pol, G. Kersten, C. V. van Els, 2009, Expert review of vaccines.

Quality-control issues and approaches in vaccine

Leo A. van der Pol, Bernard Metz, Cécile A. C. M. van Els, 2009 .

Trypsin diminishes the rat potency of polio serotype 3.

G. Kersten, B. Metz, A. de Haan, 2015, Biologicals : journal of the International Association of Biological Standardization.